Labcorp became the first U.S. commercial laboratory to launch COVID-19 PCR testing on March 5, 2020, and less than two weeks later it became the first to receive FDA Emergency Use Authorization (EUA).

Modern diagnostic methods allow growers to detect pathogens earlier and identify disease pressure with far greater precision than traditional testing methods.

Expanding access to advanced PCR thermocyclers, DNA & RNA purification systems, and hematology analyzers for modern clinical laboratories SINGAPORE, SG / ACCESS Newswire / March 7, 2026 / Dipylon ...

ITHACA, N.Y.--(BUSINESS WIRE)--Rheonix Inc., a manufacturer of a highly advanced microfluidic molecular testing platform, announced the opening of Rheonix Laboratories LLC, a CLIA-certified clinical ...

Expands range of applications for successful QIAcuity digital PCR platforms, now entering the clinical space across North America and the EU // Provides absolute quantitation, essential for precise ...

$5 million donation covering no-cost tests across locations in Los Angeles and Orange County Our mission at Pangea Laboratory has always been to make quality healthcare more accessible and affordable.

This decision, well within current norms for care, was nonetheless consequential: The president was forced to cancel a trip to advocate for legislation in support of the domestic semiconductor ...

The COVID-19 pandemic brought the term "Polymerase Chain Reaction testing" into the mainstream. The PCR method is a type of ...

PCR tests, also called molecular tests or nucleic acid tests, are considered the gold standard in detecting the presence of SARS-CoV-2, the virus that gives rise to COVID-19. However, they can take a ...